Fizazi, K., Azad, A. A., Matsubara, N., Carles, J., Fay, A. P., Giorgi, U. d., . . . Agarwal, N. (2024). First-line talazoparib with enzalutamide in HRR-deficient metastatic castration-resistant prostate cancer: The phase 3 TALAPRO-2 trial. Nature medicine, 30(1), . https://doi.org/10.1038/s41591-023-02704-x
Chicago-Zitierstil (17. Ausg.)Fizazi, Karim, et al. "First-line Talazoparib with Enzalutamide in HRR-deficient Metastatic Castration-resistant Prostate Cancer: The Phase 3 TALAPRO-2 Trial." Nature Medicine 30, no. 1 (2024). https://doi.org/10.1038/s41591-023-02704-x.
MLA-Zitierstil (9. Ausg.)Fizazi, Karim, et al. "First-line Talazoparib with Enzalutamide in HRR-deficient Metastatic Castration-resistant Prostate Cancer: The Phase 3 TALAPRO-2 Trial." Nature Medicine, vol. 30, no. 1, 2024, https://doi.org/10.1038/s41591-023-02704-x.